Showing results (1181-1190 of 6,130) with videos related to
Sort By:
Pageof 613
International Journal of Antimicrobial Agents|October 19, 2019
World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forwardArmand Van Deun, Tom Decroo, Sabira Tahseen, et al.International Journal of Antimicrobial Agents|October 13, 2021
Clinical and bacterial characteristics of Pseudomonas aeruginosa affecting the outcome of patients with bacteraemic pneumoniaRaúl Recio, Esther Viedma, Sara González-Bodí, et al.International Journal of Antimicrobial Agents|March 15, 2022
Silent circulation of BKC-1-producing Klebsiella pneumoniae ST442: molecular and clinical characterization of an early and unreported outbreakWillames M B S Martins, Michael H Lenzi, Ana C Narciso, et al.International Journal of Antimicrobial Agents|March 15, 2022
Recommended Antibiotic Dosage Regimens in Critically Ill Patients with Augmented Renal Clearance: A Systematic ReviewCatarina Mendes Silva, João Pedro Baptista, Iolanda Santos, et al.International Journal of Antimicrobial Agents|March 1, 2022
Survey of delivery of parenteral antimicrobials in non-inpatient settings across EuropeCaroline Emilie, Phebe de Nocker, Nadia Saïdani, et al.International Journal of Antimicrobial Agents|October 18, 2019
Anidulafungin as an alternative treatment for Pneumocystis jirovecii pneumonia in patients who cannot tolerate trimethoprim/sulfamethoxazolePo-Yi Chen, Chong-Jen Yu, Jung-Yien Chien, et al.International Journal of Antimicrobial Agents|September 21, 2021
Activity of ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam against carbapenemase-negative carbapenem-resistant Enterobacterales isolates from US hospitalsMariana Castanheira, Timothy B Doyle, Lalitagauri M Deshpande, et al.International Journal of Antimicrobial Agents|September 21, 2021
Antimicrobial Susceptibility among Gram-Negative Isolates in Pediatric Patients in Europe from 2013-2018 Compared to 2004-2012: Results from the ATLAS Surveillance StudyHarald Seifert, Marie-Louise von Linstow, Hester Janssen, et al.International Journal of Antimicrobial Agents|December 18, 2009
Activity of aminocandin (IP960; HMR3270) compared with amphotericin B, itraconazole, caspofungin and micafungin in neutropenic murine models of disseminated infection caused by itraconazole-susceptible and -resistant strains of Aspergillus fumigatusPeter A Warn, Andrew Sharp, Graham Morrissey, et al.International Journal of Antimicrobial Agents|June 17, 2019
Pharmacokinetics of pyrazinamide during the initial phase of tuberculous meningitis treatmentR Stemkens, C H C Litjens, S Dian, et al.Pageof 613